Vanberra Signal

Coagulo

Curated by Signal

Provider of precision-medicine platform for diagnosis blood coagulation disease

Overview

Coagulo provides a precision-medicine platform for the diagnosis of blood coagulation disease. They provide microfluidic technology and proprietary data analytics and digital connectivity. The company's new point-of-care testing platform delivers accessible and personalized diagnosis and management of all coagulation-related diseases. The platform detects, identifies, and quantifies the effect of all anticoagulants in whole blood and communicates actionable results to healthcare providers. The software has features like the portable and automated reader, trend monitoring and treatment optimization, and personalized diagnosis and management.

Key facts

Founded
2018

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of data warehouse solutions for healthcare providers

    Health TechnologySt. Louis, United States
  • Provider of an AI-enabled computational pathology and diagnostic tool for providers and researchers

    Health TechnologyNew York City, United States
  • Provider of an online doctor & hospital listing platform

    Health TechnologyLouisville, United States

About Coagulo

What does Coagulo do?

Coagulo provides a precision-medicine platform for the diagnosis of blood coagulation disease.

Where is Coagulo headquartered?

Coagulo is headquartered in Newton, United States.

When was Coagulo founded?

Coagulo was founded in 2018.

Which sector is Coagulo in?

Coagulo operates in Health Technology.

Who are Coagulo's competitors?

Companies similar to Coagulo include Calculated Health, PAIGE, and Medvoucher.